BioAesthetics Corporation today announced that it has doubled its initial Series A funding goal of $2.5 million, closed on Dec. 30, 2020, at $5 million to commercialize its NACgraft biologic matrix— a regenerative nipple graft for breast cancer survivors. BioAesthetics’ Series A was co-led by FemHealth Ventures and personally by BioAesthetics’ Director Sandra Coufal, MD, of Sibling Capital Ventures. BioAesthetics’ inaugural product, the NACgraft — for patients…
Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions to invest in innovative health care companies, today announced the formation of the Echo Innovation Alliance, a powerful strategic investing engine that extends Echo’s proven investment model. Echo and USAble Corporation will collaborate through the newly formed Alliance to invest in transformative companies and drive broader market impact.…
Roche today announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. The image analysis algorithms use artificial intelligence to support pathologists in making faster, more accurate patient diagnoses in breast cancer. The uPath image analysis algorithm suite…
Building on its 173-year history of advancing medicine, science and public health, The New York Academy of Medicine (NYAM) has announced its convening of NYC and national experts to advance research and policy change for maternal and child health equity. NYAM recently launched a 13-member Women’s Health Research & Well-being Workgroup, and on January 12, 2021 will host a virtual Maternal and Child…
Sera Prognostics, a company focused on improving maternal and neonatal health through innovative precision biomarker approaches, together with leading health benefits company Anthem and its HealthCore subsidiary, an evidence generation company, have launched and started to enroll patients in a study to determine whether a test, along with clinical interventions, can lead to improved health for newborns and mothers. The primary objective…
Portolia’s Active Aging and Longevity Fund will be closing on January 31, 2021. The fund is focused in two areas: emerging solutions that will improve longevity and vitality, and new technologies and that enhance the aging experience for people over 50, as well those caring for the elderly. Women inform $5-15 Trillion of US spending and are often the leaders when considering options…
Women’s Health USA, a provider of practice management and emerging value-based care services to more than 600 women’s health providers across seven states, announced today that Goran Dragolovic is stepping down as the organization’s CEO to assume a leadership role at Covenant Physician Partners, a KKR portfolio company that provides physician practice and surgery center services. Upon his departure, Sverica Capital Management,…
Earlier today Willow, the femtech company that changed the way women pump with the first quiet, all-in-one, in-bra wearable breast pump, announced Willow Generation 3, the most advanced model yet, will be available this spring. The next iteration of Willow’s life-changing breast pump features groundbreaking technology that reinforces their commitment to create the smartest and most productive pumping experience for moms. In testing,…
